Advanced Multiple Sclerosis
Neurology·MeSH: Multiple Sclerosis
Prevalence
120.0 / 100K
Incidence
7.0 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| Cladribine | UNITED THERAPEUTICS Corp (UTHR) |
Frequently asked questions
How many drugs are in development for Advanced Multiple Sclerosis?
BioSniper tracks 1 drug in development for Advanced Multiple Sclerosis across 1 company.
How many clinical trials target Advanced Multiple Sclerosis?
There are 1 clinical trial targeting Advanced Multiple Sclerosis tracked by BioSniper.
What is the prevalence of Advanced Multiple Sclerosis?
The estimated prevalence of Advanced Multiple Sclerosis is approximately 120.0 per 100,000 population.
Deep-dive into Advanced Multiple Sclerosis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis